A one-time cell therapy from Kyverna Therapeutics for stiff person syndrome, a rare disease, improved mobility and reduced disabilities in a late-stage trial.
At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared the state of cancer research steady.
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients.
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
Schools, colleges and other public institutions originally had until this week to make online content accessible to people with disabilities. Now, the Justice Department has delayed that deadline.
Health Secretary Robert F. Kennedy Jr. faced tough questioning as he caps off seven hearings on the Hill in as many days. It's the first time he has testified before Congress since September.
President Trump has signed an executive order aimed at accelerating research and approval of psychedelics for treating mental health conditions, like depression, PTSD and addiction.
"Men can't see the mess." "Women are better at chores." These myths position women to take on more emotional thinking, says researcher Leah Ruppanner. She shares what works to reclaim your headspace.
Taken together, these four features can create a trancelike state that can keep us stuck on social media apps or video games for hours. Children are particularly vulnerable.